Down 50%, Is Novavax Stock a Great Buy Now?
Over the past year, Novavax (NASDAQ: NVAX) stock has swung between extremely overvalued and extremely undervalued, with a share price ranging from a low of $40.50 to a high of $331.68. It's currently down more than 50% from those all-time highs, which it reached in February.
Investors were thrilled that the company had developed a solid coronavirus vaccine candidate, but were then shocked by its logistical problems. Is now the time to buy the dip?
Image source: Getty Images.
Source Fool.com
